Although the mechanisms are not fully understood, leptin signaling, insulin signaling, mitochondrial metabolism, and the NF-κB pathway, all involving CRP, are the potential factors that modulate NAFLD/MASLD (Figure 2). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.